Clinical Trial Update: The DESyne BDS Plus RCT: A Randomized Clinical Trial to Assess the Elixir DESyne BDS Plus Drug Eluting Coronary Stent System for the Treatment of de Novo Native Coronary Artery Lesions [Phase 2]

View source ↗

Summary

Phase 2 randomized trial of the DESyne BDS Plus drug-eluting coronary stent system for de novo native coronary artery lesions; the study is currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• DESyne BDS Plus Drug Eluting Coronary Stent System (drug-eluting coronary stent system)

Snippet

Sponsor: Elixir Medical Corporation | Conditions: Coronary Artery Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING